MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines

Journal of Biological Chemistry

Volumn 292, Issue 1, 2017, Pages 82-99

  Terashima, Minoru ^a   Tange, Shoichiro ^a   Ishimura, Akihiko ^a   Suzuki, Takeshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; AMINO ACIDS; BIOLOGICAL ORGANS; CELL CULTURE; CHROMOSOMES; DISEASES; GENE EXPRESSION; GENES; METHYLATION;

CHROMATIN IMMUNOPRECIPITATION; EPIGENETIC REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN LUNG CANCER CELL LINE; IMMUNOPRECIPITATIONS; PATHOLOGICAL PROCESS; TRANSCRIPTIONAL REPRESSION; TRANSFORMING GROWTH FACTOR BETA;

RNA;

HISTONE H3; LONG UNTRANSLATED RNA; MEG3 LONG UNTRANSLATED RNA; MICRORNA 200; NUCLEIC ACID BINDING PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN JARID2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN; CHROMATIN; HISTONE; MEG3 NON-CODING RNA, HUMAN; MESSENGER RNA; MICRORNA;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; ENZYME REGULATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE TARGETING; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LUNG CANCER; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; APOPTOSIS; CELL PROLIFERATION; CHROMATIN; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; IMMUNOPRECIPITATION; LUNG TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CADHERINS; CELL PROLIFERATION; CHROMATIN; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MICRORNAS; POLYCOMB REPRESSIVE COMPLEX 2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 85009273122     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.750950     Document Type: Article

References (56)

1. Bannister, A. J., and Kouzarides, T. (2011) Regulation of chromatin by histone modifications. Cell Res. 21, 381-395
2. Greer, E. L., and Shi, Y. (2012) Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357
3. Kooistra, S. M., and Helin, K. (2012) Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13, 297-311
4. Suzuki, T., Terashima, M., Tange, S., and Ishimura, A. (2013) Roles of histone methyl-modifying enzymes in development and progression of cancer. Cancer Sci. 104, 795-800
5. Suzuki, T., Shen, H., Akagi, K., Morse, H. C., Malley, J. D., Naiman, D. Q., Jenkins, N. A., and Copeland, N. G. (2002) New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32, 166-174
6. Suzuki, T., Minehata, K., Akagi, K., Jenkins, N. A., and Copeland, N. G. (2006) Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J. 25, 3422-3431
7. Yoshida, M., Ishimura, A., Terashima, M., Enkhbaatar, Z., Nozaki, N., Satou, K., and Suzuki, T. (2011) PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells. Biochem. J. 437, 555-564
8. Enkhbaatar, Z., Terashima, M., Oktyabri, D., Tange, S., Ishimura, A., Yano, S., and Suzuki, T. (2013) KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family. Cell Cycle 12, 2100-2112
9. Oktyabri, D., Ishimura, A., Tange, S., Terashima, M., and Suzuki, T. (2016) DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines. Biochimie 123, 20-31
10. Kalluri, R., and Weinberg, R. A. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428
11. Miyazono, K., Ehata, S., and Koinuma, D. (2012) Tumor-promoting functions of transforming growth factor in progression of cancer. Uppsala J. Med. Sci. 117, 143-152
12. Tam, W. L., and Weinberg, R. A. (2013) The epigenetics of epithelialmesenchymal plasticity in cancer. Nat. Med. 19, 1438-1449
13. Wang, Y., and Shang, Y. (2013) Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp. Cell Res. 319, 160-169
14. Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R. S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Yu, J., Kleer, C. G., Varambally, S., and Chinnaiyan, A. M. (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27, 7274-7284
15. Lin, T., Ponn, A., Hu, X., Law, B. K., and Lu, J. (2010) Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29, 4896-4904
16. Oktyabri, D., Tange, S., Terashima, M., Ishimura, A., and Suzuki, T. (2014) EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF. Biochem. Biophys. Res. Commun. 453, 124-130
17. Margueron, R., and Reinberg, D. (2011) The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349
18. Di Croce, L., and Helin, K. (2013) Transcriptional regulation by Polycomb group proteins. Nat. Struct. Mol. Biol. 20, 1147-1155
19. Chase, A., and Cross, N. C. (2011) Aberrations of EZH2 in cancer. Clin. Cancer Res. 17, 2613-2618
20. Peng, J. C., Valouev, A., Swigut, T., Zhang, J., Zhao, Y., Sidow, A., and Wysocka, J. (2009) Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139, 1290-1302
21. Shen, X., Kim, W., Fujiwara, Y., Simon, M. D., Liu, Y., Mysliwiec, M. R., Yuan, G. C., Lee, Y., and Orkin, S. H. (2009) Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139, 1303-1314
22. Pasini, D., Cloos, P. A., Walfridsson, J., Olsson, L., Bukowski, J. P., Johansen, J. V., Bak, M., Tommerup, N., Rappsilber, J., and Helin, K. (2010) JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464, 306-310
23. Li, G., Margueron, R., Ku, M., Chambon, P., Bernstein, B. E., and Reinberg, D. (2010) Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 24, 368-380
24. Tange, S., Oktyabri, D., Terashima, M., Ishimura, A., and Suzuki, T. (2014) JARID2 is involved in transforming growth factor-induced epithelialmesenchymal transition of lung and colon cancer cell lines. PLoS One 9, e115684
25. Guttman, M., and Rinn, J. L. (2012) Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346
26. Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., Poliakov, A., Cao, X., Dhanasekaran, S. M., Wu, Y. M., Robinson, D. R., et al. (2015) The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199-208
27. Yan, X., Hu, Z., Feng, Y., Hu, X., Yuan, J., Zhao, S. D., Zhang, Y., Yang, L., Shan, W., He, Q., Fan, L., Kandalaft, L. E., Tanyi, J. L., Li, C., Yuan, C. X., et al. (2015) Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 28, 529-540
28. Bartonicek, N., Maag, J. L., and Dinger, M. E. (2016) Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol. Cancer 15, 43
29. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., and Chang, H. Y. (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323
30. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756
31. Scheel, C., and Weinberg, R. A. (2012) Cancer stem cells and epithelialmesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22, 396-403
32. Hu, W., Alvarez-Dominguez, J. R., and Lodish, H. F. (2012) Regulation of mammalian cell differentiation by long non-coding RNAs.EMBORep. 13, 971-983
33. Ghosal, S., Das, S., and Chakrabarti, J. (2013) Long noncoding RNAs: new players in the molecular mechanism for maintenance and differentiation of pluripotent stem cells. Stem Cells Dev. 22, 2240-2253
34. Kaneko, S., Bonasio, R., Saldaña-Meyer, R., Yoshida, T., Son, J., Nishino, K., Umezawa, A., and Reinberg, D. (2014) Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol. Cell 53, 290-300
35. da Rocha, S. T., Boeva, V., Escamilla-Del-Arenal, M., Ancelin, K., Granier, C., Matias, N. R., Sanulli, S., Chow, J., Schulz, E., Picard, C., Kaneko, S., Helin, K., Reinberg, D., Stewart, A. F., Wutz, A., et al. (2014) Jarid2 is implicated in the initial xist-induced targeting of PRC2 to the inactive X chromosome. Mol. Cell 53, 301-316
36. Kimura, H., Hayashi-Takanaka, Y., Goto, Y., Takizawa, N., and Nozaki, N. (2008) The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 33, 61-73
37. Chu, C., Quinn, J., and Chang, H. Y. (2012) Chromatin isolation by RNA purification (ChIRP). J. Vis. Exp. 61, 3912
38. Kasai, H., Allen, J. T., Mason, R. M., Kamimura, T., and Zhang, Z. (2005) TGF1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6, 56
39. Peinado, H., Olmeda, D., and Cano, A. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428
40. Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., and Goodall, G. J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601
41. Park, S. M., Gaur, A. B., Lengyel, E., and Peter, M. E. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907
42. Siegel, P. M., and Massagué, J. (2003) Cytostatic and apoptotic actions of TGF in homeostasis and cancer. Nat. Rev. Cancer 3, 807-821
43. Koinuma, D., Tsutsumi, S., Kamimura, N., Taniguchi, H., Miyazawa, K., Sunamura, M., Imamura, T., Miyazono, K., and Aburatani, H. (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor signaling. Mol. Cell. Biol. 29, 172-186
44. Davalos, V., Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., and Esteller, M. (2012) Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 31, 2062-2074
45. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., and Chang, H. Y. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693
46. Zhao, J., Ohsumi, T. K., Kung, J. T., Ogawa, Y., Grau, D. J., Sarma, K., Song, J. J., Kingston, R. E., Borowsky, M., and Lee, J. T. (2010) Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939-953
47. Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T. K., Koche, R. P., Lee, W., Mendenhall, E., O'Donovan, A., Presser, A., Russ, C., et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560
48. Ke, X. S., Qu, Y., Cheng, Y., Li, W. C., Rotter, V., Oyan, A. M., and Kalland, K. H. (2010) Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics 11, 669
49. Piunti, A., and Shilatifard, A. (2016) Epigenetic balance of gene expression by Polycomb and COMPASS families. Science 352, aad9780
50. Zhou, Y., Zhang, X., and Klibanski, A. (2012) MEG3 noncoding RNA: A tumor suppressor. J. Mol. Endocrinol. 48, R45-R53
51. Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y., Cheunsuchon, P., Louis, D. N., and Klibanski, A. (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 70, 2350-2358
52. Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., and Patel, T. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30, 4750-4756
53. Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J., Weng, C., and Klibanski, A. (2007) Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742
54. Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., Hochhaus, A., Drexler, H. G., Duncombe, A., Cervantes, F., Oscier, D., et al. (2010) Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42, 722-726
55. Puda, A., Milosevic, J. D., Berg, T., Klampfl, T., Harutyunyan, A. S., Gisslinger, B., Rumi, E., Pietra, D., Malcovati, L., Elena, C., Doubek, M., Steurer, M., Tosic, N., Pavlovic, S., Guglielmelli, P., et al. (2012) Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. Am. J. Hematol. 87, 245-250
56. Walters, Z. S., Villarejo-Balcells, B., Olmos, D., Buist, T. W., Missiaglia, E., Allen, R., Al-Lazikani, B., Garrett, M. D., Blagg, J., and Shipley, J. (2014) JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells. Oncogene 33, 1148-1157